发明名称 Method for simultaneously determining multiple coagulation proteases
摘要 The present invention relates to a chromogenic method for simultaneously determining the activity of multiple coagulation proteases or for simultaneously determining the inhibition of multiple coagulation proteases in a single test reaction. For this purpose, use is made of two chromogenic substrates which have different absorption maxima and whose color signals can be separated spectrally.
申请公布号 US9482673(B2) 申请公布日期 2016.11.01
申请号 US201514589425 申请日期 2015.01.05
申请人 SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH 发明人 Zander Norbert
分类号 C12Q1/56;C12Q1/37;C12N9/50;G01N33/573 主分类号 C12Q1/56
代理机构 Slayden Grubert Beard PLLC 代理人 Slayden Grubert Beard PLLC
主权项 1. A method for determining anti-thrombin and anti-factor Xa anticoagulant concentrations in a test sample which contains human plasma and which is suspected of containing an anti-thrombin anticoagulant, an anti-factor Xa anticoagulant, or a combination thereof, the method comprising: performing a single test reaction by mixing the test sample which contains the human plasma and which is suspected of containing the anti-thrombin anticoagulant, the anti-factor Xa anticoagulant, or the combination thereof, with selected substances including (a) a defined amount of thrombin, (b) a defined amount of factor Xa, (c) a first chromogenic substrate specific for thrombin, and (d) a second chromogenic substrate specific for factor Xa, wherein a chromophore of the first chromogenic substrate and a chromophore of the second chromogenic substrate have respective absorption maximums that differ by at least 100 nm; photometrically determining absorption changes in the single test reaction over time; comparing the photometrically determined absorption changes in the single test reaction with photometrically determined absorption changes occurring in a control test reaction between an anticoagulant-free control sample and the selected substances; determining inhibition of the absorption changes caused by the anti-thrombin and/or anti-factor Xa anticoagulants in the test sample based on the comparison of the photometrically determined absorption changes; and determining the anti-thrombin and anti-factor Xa anticoagulant concentrations in the test sample based on the inhibition of the absorption changes in the single test reaction.
地址 Marburg DE